Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 30thDecember 2014
Summary The industry analysis specialist, has released its new report, “Laryngeal Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Laryngeal Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Laryngeal Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Laryngeal Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-laryngeal-cancer-therapeutics-pipeline-assessment-and-marketforecasts-135234 Scope The report provides information on the key drivers and challenges of the Laryngeal Cancer Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Laryngeal Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Cancer Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Laryngeal Cancer Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Laryngeal Cancer Therapeutics market. - Analysis of key recent licensing and partnership agreements in Laryngeal Cancer Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Laryngeal Cancer Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Laryngeal Cancer Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Laryngeal Cancer Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Laryngeal Cancer Therapeutics - Introduction 2.1 Disease Overview 2.2 Epidemiology 2.3 Etiology and Risk Factors 2.4 Signs and Symptoms 2.5 Diagnosis 2.6 Staging (TNM Classification) 2.7 Treatment 2.7.1 Treatment by Stage of the Disease 2.7.2 Surgery 2.7.3 Radiation Therapy 2.7.4 Chemotherapy 2.7.5 Targeted Therapy 2.8 GlobalData Pipeline Report Guidance 3 Laryngeal Cancer Therapeutics - Market Characterization 3.1 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Global 3.2 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Global 3.3 Laryngeal Cancer Therapeutics Market Size (2006-2011) - The US Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.4 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - The US 3.5 Laryngeal Cancer Therapeutics Market Size (2006-2011) - The UK 3.6 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - The UK 3.7 Laryngeal Cancer Therapeutics Market Size (2006-2011) - France 3.8 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - France 3.9 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Germany 3.10 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Germany 3.11 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Italy 3.12 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Italy 3.13 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Spain 3.14 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Spain 3.15 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Japan 3.16 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for Laryngeal Cancer Therapeutic Market 3.17.1 Drivers for the Laryngeal Cancer Therapeutics Market 3.17.2 Barriers for the Laryngeal Cancer Therapeutics Market 3.18 Key Events Impacting the Future Market 3.19 Opportunity and Unmet Need 3.20 Key Takeaway 4 Laryngeal Cancer Therapeutics Market - Competitive Assessment 4.1 Overview 4.1.1 Strategic Competitor Assessment 4.2 Laryngeal Cancer Therapeutics - Profile for Marketed Products 4.2.1 Erbitux (cetuximab) 4.2.2 Taxotere (docetaxel) 4.2.3 Bleomycin 4.3 Key Takeaway 5 Laryngeal Cancer Therapeutics Market - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Laryngeal Cancer Pipeline Analysis - Pipeline by Phases of Development 5.3.1 Laryngeal Cancer Therapeutics - Phase III Pipeline 5.3.2 Laryngeal Cancer Therapeutics - Phase II Pipeline 5.3.3 Laryngeal Cancer Therapeutics - Phase I/II Pipeline 5.3.4 Laryngeal Cancer Therapeutics - Phase I Pipeline 5.4 Laryngeal Cancer Pipeline by Mechanism of Action 5.5 Laryngeal Cancer Technology Trends Analytical Framework 5.6 Laryngeal Cancer Therapeutics - Profile for Late Stage Molecules 5.6.1 Bevacizumab Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.6.2 Panitumumab 5.6.3 S-1 5.7 Key Takeaway 6 Laryngeal Cancer Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials Mapping by Region/Country 6.2 Clinical Trials Mapping by Phase 6.3 Clinical Trials Mapping by Trial Status 6.4 Clinical Trials Mapping by Overall Sponsors 6.5 Clinical Trial Mapping by Prominent Sponsors 7 Laryngeal Cancer Therapeutics - Strategic Assessment 7.1 Future Market Competition Scenario 8 Laryngeal Cancer Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Amgen Inc. 9 Global Laryngeal Cancer Therapeutics Market - Appendix 9.1 Definitions 9.2 Acronyms 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Laryngeal Cancer - Epidemiology 2010 Table 2: Stage Distribution and Five-year Relative Survival by Stage at Diagnosis for 2001-2007 Table 3: Laryngeal Cancer , TNM Definitions Table 4: Laryngeal Cancer - Anatomic Stage/Prognostic Groups and Development of Cancer Cells Table 5: Laryngeal Cancer Treatment Options by Stages Table 6: Laryngeal Cancer - Chemotherapy with Radiation Therapy for Locally Advanced Stages (Stage III - IVB) Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 7: Laryngeal Cancer - Induction Chemotherapy for Locally Advanced Stages III-IVB Table 8: Laryngeal Cancer - First-Line Chemotherapy for Metastatic or Recurrent Stage IVC Table 9: Laryngeal Cancer , Second and Third-Line Chemotherapy for Metastatic or Recurrent Stage (Stage IVC) Table 10: Laryngeal Cancer Therapeutics, Global, Market Revenue ($m), 2006-2011 Table 11: Laryngeal Cancer Therapeutics, Global, Forecast ($m), 2011-2019 Table 12: Laryngeal Cancer Therapeutics, The US, Market Revenue ($m), 2006-2011 Table 13: Laryngeal Cancer Therapeutics, The US, Forecast ($m), 2011-2019 Table 14: Laryngeal Cancer Therapeutics, The UK, Market Revenue ($m), 2006-2011 Table 15: Laryngeal Cancer Therapeutics, The UK, Forecast ($m), 2011-2019 Table 16: Laryngeal Cancer Therapeutics, France, Market Revenue ($m), 2006-2011 Table 17: Laryngeal Cancer Therapeutics, France, Forecast ($m), 2011-2019 Table 18: Laryngeal Cancer Therapeutics, Germany, Market Revenue ($m), 2006-2011 Table 19: Laryngeal Cancer Therapeutics, Germany, Forecast ($m), 2011-2019 Table 20: Laryngeal Cancer Therapeutics, Italy, Market Revenue ($m), 2006-2011 Table 21: Laryngeal Cancer Therapeutics, Italy, Forecast ($m), 2011-2019 Table 22: Laryngeal Cancer Therapeutics, Spain, Market Revenue ($m), 2006-2011 Table 23: Laryngeal Cancer Therapeutics, Spain, Forecast ($m), 2011-2019 Table 24: Laryngeal Cancer Therapeutics, Japan, Market Revenue ($m), 2006-2011 Table 25: Laryngeal Cancer Therapeutics, Japan, Forecast ($m), 2011-2019 Table 26: Laryngeal Cancer Therapeutics - Phase III Pipeline, 2011 Table 27: Laryngeal Cancer Therapeutics - Phase II Pipeline, 2011 Table 28: Laryngeal Cancer Therapeutics - Phase I/II Pipeline, 2011 Table 29: Laryngeal Cancer Therapeutics - Phase I Pipeline, 2011 Table 30: Laryngeal Cancer Therapeutics - Clinical Mapping by Region/Country, 2011 Table 31: Laryngeal Cancer Therapeutics - Clinical Mapping by Phase, 2011 Table 32: Laryngeal Cancer Therapeutics - Clinical Mapping by Trial Status, 2011 Table 33: Laryngeal Cancer Therapeutics - Clinical Mapping by Overall Sponsors, 2011 Table 34: Laryngeal Cancer Therapeutics - Clinical Mapping by Prominent Sponsors, 2011 Table 35: Amgen - Molecule in the Pipeline for Head and Neck Cancer, 2011
List Of Figures Figure 1: Laryngeal Cancer - Disease Characterization Figure 2: Laryngeal Cancer Therapeutics, Global, Market Revenue ($m), 2006-2011 Figure 3: Laryngeal Cancer Therapeutics, Market Share ($m, %), 2011 Figure 4: Laryngeal Cancer Therapeutics, Global, Forecast ($m), 2011-2019 Figure 5: Laryngeal Cancer Therapeutics, Market Share ($m, %), 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 6: Laryngeal Cancer Therapeutics, The US, Market Revenue ($m), 2006-2011 Figure 7: Laryngeal Cancer Therapeutics, The US, Forecast ($m), 2011-2019 Figure 8: Laryngeal Cancer Therapeutics, The UK, Market Revenue ($m), 2006-2011 Figure 9: Laryngeal Cancer Therapeutics, The UK, Forecast ($m), 2011-2019 Figure 10: Laryngeal Cancer Therapeutics, France, Market Revenue ($m), 2006-2011 Figure 11: Laryngeal Cancer Therapeutics, France, Forecast ($m), 2011-2019 Figure 12: Laryngeal Cancer Therapeutics, Germany, Market Revenue ($m), 2006-2011 Figure 13: Laryngeal Cancer Therapeutics, Germany, Forecast ($m), 2011-2019 Figure 14: Laryngeal Cancer Therapeutics, Italy, Market Revenue ($m), 2006-2011 Figure 15: Laryngeal Cancer Therapeutics, Italy, Forecast ($m), 2011-2019 Figure 16: Laryngeal Cancer Therapeutics, Spain, Market Revenue ($m), 2006-2011 Figure 17: Laryngeal Cancer Therapeutics, Spain, Forecast ($m), 2011-2019 Figure 18: Laryngeal Cancer Therapeutics, Japan, Market Revenue ($m), 2006-2011 Figure 19: Laryngeal Cancer Therapeutics, Japan, Forecast ($m), 2011-2019 Figure 20: Laryngeal Cancer Therapeutics, Key Events Impacting the Future Market, 2011 Figure 21: Opportunity and Unmet Need in the Laryngeal Cancer Therapeutics Market, 2011 Figure 22: Laryngeal Cancer Therapeutics, Strategic Competitor Assessment, 2011 Figure 23: Laryngeal Cancer Therapeutics - Pipeline by Phase of Development, 2011 Figure 24: Laryngeal Cancer Market - Clinical Pipeline by Mechanism of Action, 2011 Figure 25: Technology Trends Analytical Framework of the Laryngeal Cancer Pipeline, 2011 Figure 26: Technology Trends Analytical Framework of Laryngeal Cancer Pipeline - Description, 2011 Figure 27: Laryngeal Cancer Therapeutics - Clinical Mapping by Region/Country, 2011 Figure 28: Laryngeal Cancer Therapeutics - Clinical Mapping by Phase, 2011 Figure 29: Laryngeal Cancer Therapeutics - Clinical Mapping by Trial Status, 2011 Figure 30: Laryngeal Cancer Therapeutics - Clinical Mapping by Overall Sponsors, 2011 Figure 31: Laryngeal Cancer Therapeutics - Clinical Mapping by Prominent Sponsors, 2011 Figure 32: Laryngeal Cancer Therapeutics, Strategic Assessment, 2011 Figure 33: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Related Reports: Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-laryngeal-cancertherapeutics-pipeline-assessment-and-market-forecasts-135234 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/